Related Experiment Video
Updated: Mar 26, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
Hitting a Moving Target: How Does an N-Methyl Group Impact Biological Activity?
Yen Chin Koay1, Nicole L Richardson1, Samantha S Zaiter1
1Department of Chemistry, University of New South Wales, Gate 2 High Street, Dalton F12, Sydney, NSW, 2008, Australia.
Macrocyclic peptides offer advantages for targeting protein-protein interactions. N-methylation of these cyclic peptides alters their shape, significantly impacting heat-shock protein 90 (Hsp90) inhibition and cytotoxicity.
Area of Science:
- Medicinal Chemistry
- Chemical Biology
- Drug Discovery
Background:
- Macrocycles are promising therapeutic agents, particularly for inhibiting challenging protein-protein interactions.
- Heat-shock protein 90 (Hsp90) is an oncogenic regulator and a validated target in cancer therapy.
- Modulating macrocycle conformation is key to optimizing drug efficacy.
Purpose of the Study:
- To synthesize novel cyclic peptide macrocycles with varying N-methylation patterns.
- To investigate the impact of N-methylation position on macrocycle conformation and biological activity.
- To evaluate the Hsp90 inhibitory potential of potent N-methylated macrocycle analogues.
Main Methods:
- Synthesis of seven cyclic peptide analogues.
- Conformational analysis of macrocycles.
- Assessment of cytotoxicity against cancer cell lines.
- Measurement of binding affinity to heat-shock protein 90 (Hsp90).
Main Results:
- N-methylation significantly altered macrocycle conformation.
- Conformational changes led to dramatic differences in cytotoxicity.
- Binding affinity for Hsp90 was modulated by N-methylation.
- Specific N-methylation positions resulted in potent Hsp90 inhibition.
Conclusions:
- The placement of N-methylated amino acids in cyclic peptides unpredictably influences their three-dimensional structure.
- Macrocycle conformation is a critical determinant of biological activity, including cytotoxicity and target engagement.
- N-methylated macrocycles represent a viable strategy for developing novel Hsp90 inhibitors.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...

